Evidence map›Paper›PMID 37709735›Full record

ArticleNature communications2023

A biocatalytic platform for asymmetric alkylation of α-keto acids by mining and engineering of methyltransferases.

Shuyun Ju, Kaylee P Kuzelka, Rui Guo, Benjamin Krohn-Hansen, Jianping Wu, Satish K Nair, Yang Yang

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Enantioselective β-C(spJournal of the American Chemical Society · 2025
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shuyun Ju *Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA.ORCID http://orcid.org/0000-0002-0322-104X
Kaylee P Kuzelka *Department of Biochemistry, Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Rui GuoDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA.
Benjamin Krohn-HansenDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA.ORCID http://orcid.org/0000-0003-3498-0660
Jianping WuDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA.
Satish K NairDepartment of Biochemistry, Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA. snair@illinois.edu.ORCID http://orcid.org/0000-0003-1790-1334
Yang YangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA. yang@chem.ucsb.edu.ORCID http://orcid.org/0000-0002-4956-2034

Funding

Structural Biological Studies of Thipeptide Biosynthesis and EngineeringR01GM131347 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NAIR, SATISH K · 2019 to 2022
$1.2M
NIGMS NIH HHS R01 GM131347
6 · The paper itself

Abstract

Catalytic asymmetric α-alkylation of carbonyl compounds represents a long-standing challenge in synthetic organic chemistry. Herein, we advance a dual biocatalytic platform for the efficient asymmetric alkylation of α-keto acids. First, guided by our recently obtained crystal structures, we develop SgvM

Indexed as

EngineeringMethyltransferasesAlkylationBiocatalysisKeto AcidsMethenaminePseudomonas aeruginosaKeto AcidsMethenamineMethyltransferases

Identifiers

PMID37709735
PMCPMC10502145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.